Breaking Catastrophic Floods Impact Nepal-China Border Following Glacier Collapse; Hundreds Dead or Missing UK Government Warns Israel Against Removing Officials from Gaza Coordination Center Attorney General Todd Blanche Defends Record Amidst Political Pressure Emily Wilson Embarks on New Translation of Homer’s ‘The Odyssey’ Crown Prince Haakon Ascends to Norwegian Throne as King Haakon VIII

Friday August 28, 2026

Reporter

LEADS BIOLABS CO., LTD.

4Articles Published

5Communities Covered

Published Articles

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage

Aug 25

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

Aug 20

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

Aug 20

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

Aug 20